Genetics of Endocrine and Neuroendocrine Neoplasias (PDQ)—Health Professional Version - National Cancer Institute || NUEVO CAPÍTULO MÉDICO 2016

Genetics of Endocrine and Neuroendocrine Neoplasias (PDQ)—Health Professional Version - National Cancer Institute

Genetics of Endocrine and Neuroendocrine Neoplasias–for health professionals (PDQ®)

THYROID CANCER

• Patient
• Health Professional
  • Thyroid Cancer Treatment
  • Genetics of Endocrine & Neuroendocrine Neoplasias
• Research

SECTIONS

• Introduction
• Multiple Endocrine Neoplasia Type 1
• Multiple Endocrine Neoplasia Type 2
• Familial Paraganglioma Syndrome
• Carney-Stratakis Syndrome
• Changes to This Summary (01/​20/​2016)
• About This PDQ Summary
• View All Sections

Changes to This Summary (01/20/2016)

The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above.

Introduction

Updated statistics with estimated new cases of multiple endocrine neoplasia type 2 (MEN2)–related medullary thyroid cancer for 2016 (cited American Cancer Society as reference 7).

Multiple Endocrine Neoplasia Type 2

Updated statistics with estimated new thyroid cancer cases and deaths for 2016 (cited American Cancer Society as reference 26).

This summary is written and maintained by the PDQ Cancer Genetics Editorial Board, which is editorially independent of NCI. The summary reflects an independent review of the literature and does not represent a policy statement of NCI or NIH. More information about summary policies and the role of the PDQ Editorial Boards in maintaining the PDQ summaries can be found on the About This PDQ Summary and PDQ® - NCI's Comprehensive Cancer Database pages.

< Previous section
Carney-Stratakis Syndrome

Next section >
About This PDQ Summary